MYGN - Financial Reports List - Myriad Genetics, Inc. - IntrinsicAlpha

Myriad Genetics, Inc. MYGN

Healthcare - Medical - Diagnostics & Research - NASDAQ - US

$ 4.07

-8.54 %

$ 375 M

Market Cap

-3.63

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q3	8-K	2024-09-30	11.15%	63.95%	66.72%
Quarterly Report	Q2	8-K	2024-06-30	15.26%	68.39%	67.90%
Quarterly Report	Q1	8-K	2024-03-31	11.59%	52.47%	46.55%
Quarterly Report	Q4	8-K	2023-12-31	10.57%	26.24%	31.74%
Annual Report	FY	10-K	2023-12-31	11.03%	-135.09%	-108.08%
Quarterly Report	Q3	8-K	2023-09-30	22.70%	-74.64%	-33.56%
Quarterly Report	Q2	8-K	2023-06-30	2.34%	-723.40%	-538.76%
Quarterly Report	Q1	8-K	2023-03-31	9.88%	-166.83%	-250.34%
Quarterly Report	Q4	8-K	2022-12-31	10.57%	-456.58%	-6.73%
Annual Report	FY	10-K	2022-12-31	-1.77%	-311.76%	-154.00%

1